Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam-remifentanil vs Propofol-remifentanil in elderly laparoscopic abdominal surgery
KCT0008005Phase 4Not yet recruiting
- Sponsor
- Dong-A University Hospital
- Start
- Dec 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam, propofol, remifentanil in postoperative delirium (POD), Neoplasm, sponsored by Dong-A University Hospital. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
remimazolampropofolremifentanil
03
Conditions
postoperative delirium (POD)Neoplasm
Beyond the preview
Go deeper on KCT0008005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008005.